Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data-La Paz, Bolivia. 2012-2017.
Adolescent
Adult
Aged
Aged, 80 and over
Bolivia
/ epidemiology
Child
Child, Preschool
Hospitalization
/ statistics & numerical data
Humans
Incidence
Infant
Influenza, Human
/ epidemiology
Middle Aged
Respiratory Syncytial Virus Infections
/ epidemiology
Respiratory Tract Infections
/ epidemiology
Risk Factors
Sentinel Surveillance
Young Adult
Bolivia
SARI
influenza
respiratory syncytial virus
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
22
02
2019
revised:
17
05
2019
accepted:
21
05
2019
pubmed:
18
6
2019
medline:
13
2
2020
entrez:
18
6
2019
Statut:
ppublish
Résumé
The objective was to estimate the number of hospitalizations associated with influenza and RSV using data from severe acute respiratory infection (SARI) sentinel surveillance from El Alto-La Paz. Bolivia. All persons who met the case definition for SARI at one sentinel hospital had a clinical sample collected and analyzed by rRT-PCR for influenza and by indirect immunofluorescence for RSV. The SARI-influenza and SARI-RSV case counts were stratified by six age groups. The proportion of cases captured in the sentinel hospital in relation to the non-sentinel hospitals of area was multiplied by the age-specific census population, to build the denominators. The annual incidence and a 95% confidence interval (CI) were estimated. During 2012-2017, n = 2606 SARI cases were reported (average incidence 120/100 000 inhabitants [95% CI: 116-124]); the average incidence of influenza-associated SARI hospitalization was 15.3/100 000 (95% CI: 14.1-16.7), and the average incidence of RSV-associated SARI hospitalization was 9/100 000 inhabitants (95% CI: 8.1-10.1). The highest incidence of influenza was among those less than one year of age (average 174.7/100 000 [range: 89.1-299.5]), followed by those one to four years of age (average 51.8/100 000 [range: 19.8-115.4]) and then those 65 years of age and older (average 47.7/100 000 [range: 18.8-117]). For RSV, the highest incidence was highest among those less than one year of age (231/100 000 [range: 119.9-322.9]). Influenza and RSV represent major causes of hospitalization in La Paz, Bolivia-with the highest burden among children under one year of age. Our estimates support current prevention strategies in this age group.
Identifiants
pubmed: 31206257
doi: 10.1111/irv.12663
pmc: PMC6692540
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
477-483Informations de copyright
© 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Références
Expert Rev Pharmacoecon Outcomes Res. 2014 Jun;14(3):425-35
pubmed: 24734967
Influenza Other Respir Viruses. 2019 Sep;13(5):477-483
pubmed: 31206257
PLoS Pathog. 2011 Sep;7(9):e1002225
pubmed: 21909272
J Pediatr. 2010 Nov;157(5):808-14
pubmed: 20580018
Bull World Health Organ. 2012 Oct 1;90(10):756-63
pubmed: 23109743
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
BMC Public Health. 2011 Nov 24;11:885
pubmed: 22111590
Influenza Other Respir Viruses. 2018 Jan;12(1):132-137
pubmed: 29446233
PLoS One. 2013;8(2):e56882
pubmed: 23573177
PLoS One. 2015 Mar 04;10(3):e0118369
pubmed: 25738736
JAMA. 2004 Sep 15;292(11):1333-40
pubmed: 15367555
Influenza Other Respir Viruses. 2018 Jan;12(1):138-145
pubmed: 29446231
Soc Sci Med. 2003 Mar;56(6):1173-82
pubmed: 12600356
Emerg Infect Dis. 2006 Jan;12(1):103-9
pubmed: 16494725
Vaccine. 2012 Mar 23;30(14):2448-52
pubmed: 22300721
BMC Infect Dis. 2018 Jun 8;18(1):269
pubmed: 29884140
Influenza Other Respir Viruses. 2016 Jul;10(4):340-5
pubmed: 26946216
J Glob Health. 2015 Dec;5(2):020101
pubmed: 26755941
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
Hum Vaccin Immunother. 2013 Apr;9(4):834-40
pubmed: 23357859
BMC Infect Dis. 2015 Oct 24;15:447
pubmed: 26497393
PLoS One. 2014 Nov 25;9(11):e113903
pubmed: 25423025
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Am J Respir Crit Care Med. 2013 Sep 15;188(6):710-5
pubmed: 23855650
Emerg Infect Dis. 2014 May;20(5):878-81
pubmed: 24750897
Lancet. 2003 Nov 22;362(9397):1733-45
pubmed: 14643124
Lancet Infect Dis. 2017 Oct;17(10):e320-e326
pubmed: 28457597